Company: MBIO
Filing Date: 2025-02-05
Form Type: S-1/A
Source: 0001104659-25-009408
Chunk: 222

Company: MUSTANG BIO, INC.
Filing Date: 2025-02-05
Form: S-1/A
Chunk 222
---
 the SEC’s website at www.sec.gov. Upon the completion of this offering, we will be subject to the information reporting requirements of the Exchange Act and we will file reports, proxy statements and other information with the SEC. These reports, proxy statements and other information will be available for review on the web site of the SEC referred to above. We also maintain a website at www.mustangbio.com, at which you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC. Information contained on or accessible through our website is not a part of this prospectus, and the inclusion of our website address in this prospectus is an inactive textual reference only.

<div align='center'>140</div>

INDEX TO FINANCIAL STATEMENTS As of and for the years ended December 31, 2023 and 2022

| Report of Independent Registered Public Accounting Firm (KPMG LLP, New York, NY; PCAOB ID: 185) 
 Balance Sheets as of December 31, 2023 and 2022                                                 
 Statements of Operations for the Years Ended December 31, 2023 and 2022                         | ​ 
 ​ | F-2 
 F-4 
 F-5 |
|:------------------------------------------------------------------------------------------------|:--|:----|
| Statements of Changes in Stockholders’ Equity for the Years Ended December 31, 2023 and 2022    | ​ | F-6 |
| Statements of Cash Flows for the Years Ended December 31, 2023 and 2022                         | ​ | F-7 |
| Notes to Financial Statements                                                                   | ​ | F-8 |

As of September 30, 2024 and for the Nine Months Ended September 30, 2024 and September 30, 2023 (Unaudited)

| Balance Sheets as of September 30, 2024 and 2023                                                    
 Statements of Operations for the Nine Months Ended September 30, 2024 and 2023                      | ​ | ​    
 F-31 
 F-32 |
|:----------------------------------------------------------------------------------------------------|:--|:-----|
| Statements of Changes in Stockholders’ Equity for the Nine Months Ended September 30, 2024 and 2023 | ​ | F-33 |
| Statements of Cash Flows for the Nine Months Ended September 30, 2024 and 2023                      | ​ | F-35 |
| Notes to Financial Statements                                                                       | ​ |